Drug Induced Cutaneous Manifestations due to Treatment of Gastrointestinal Disorders-Reference-Cited by-同舟云学术

Drug Induced Cutaneous Manifestations due to Treatment of Gastrointestinal Disorders

Published:2021-03-24 Issue:2 Volume:22 Page:99-107
ISSN:1389-2002
Container-title:Current Drug Metabolism
language:en
Short-container-title:CDM

Author:

Lalosevic Milica S.¹,Lalosevic Jovan²,Stjepanovic Mihailo³,Stojanovic Marija³,Stojkovic Mirjana³

Affiliation:

1. Clinic of Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia

2. Clinic of Dermatovenereology, Clinical Center of Serbia, Belgrade, Serbia

3. Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Abstract

Cutaneous manifestations due to drugs used in the treatment of gastrointestinal disorders are multiple and common. Adequate diagnosis is of great importance, bearing in mind that the therapeutic regimen depends on its diagnosis. In this review, we provided an overview of the most common drug-induced skin lesions with a detailed explanation of the disease course, presentation and treatment, having in mind that in recent years, novel therapeutic modalities have been introduced in the treatment of various gastrointestinal disorders, and that incidence of cutaneous adverse reactions has been on the rise.

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Pharmacology

Reference71 articles.

1. Ardern-Jones M.R.; Friedmann P.S.; Skin manifestations of drug allergy. Br J Clin Pharmacol 2011,71(5),672-683

2. Tatum A.J.; Ditto A.M.; Patterson R.; Severe serum sickness-like reaction to oral penicillin drugs: three case reports. Ann Allergy Asthma Immunol 2001,86(3),330-334

3. Zuberbier T.; Aberer W.; Asero R.; Abdul Latiff A.H.; Baker D.; Ballmer-Weber B.; Bernstein J.A.; Bindslev-Jensen C.; Brzoza Z.; Buense Bedrikow R.; Canonica G.W.; Church M.K.; Craig T.; Danilycheva I.V.; Dressler C.; Ensina L.F.; Giménez-Arnau A.; Godse K.; Gonçalo M.; Grattan C.; Hebert J.; Hide M.; Kaplan A.; Kapp A.; Katelaris C.H.; Kocatürk E.; Kulthanan K.; Larenas-Linnemann D.; Leslie T.A.; Magerl M.; Mathelier-Fusade P.; Meshkova R.Y.; Metz M.; Nast A.; Nettis E.; Oude-Elberink H.; Rosumeck S.; Saini S.S.; Sánchez-Borges M.; Schmid-Grendelmeier P.; Staubach P.; Sussman G.; Toubi E.; Vena G.A.; Vestergaard C.; Wedi B.; Werner R.N.; Zhao Z.; Maurer M.; Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GALEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO. The EAACI/GALEN/EDF/WAO Guideline for the definition, classification, diagnosis and management of urticaria. Allergy 2018,73(7),1393-1414

4. Deacock S.J.; An approach to the patient with urticaria. Clin Exp Immunol 2008,153(2),151-161

5. Shenoy E.S.; Macy E.; Rowe T.; Blumenthal K.G.; Evaluation and management of penicillin allergy: a review. JAMA 2019,321(2),188-199

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Therapeutic Molecules and their Metabolism in Gastroenterology- Part II;Current Drug Metabolism;2021-03-24